Keywords: fda, further, delays, psoriasis, drug, stelara, requests

FDA further delays J&J's psoriasis drug Stelara, requests more information

Article | 12 January 2009

Print This

The US Food and Drug Administration has announced further delays for US health care major Johnson & Johnson subsidiary Centocor's Stelara ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in